Skip to main content

Table 1 Patient characteristics

From: Predictors of treatment outcomes among patients with multidrug-resistant tuberculosis in Vietnam: a retrospective cohort study

  Hanoi province Thanh Hoa province Total
Total 494 168 662
Gender n = 494 n = 168 n = 662
 Male 365 (73.9%) 141 (83.9%) 506 (76.4%)
 Female 129 (26.1%) 27 (16.1%) 156 (23.6%)
Age (years) n = 494 n = 167 n = 661
 Mean (IQR) 43.0 (32.0–55.0) 44.0 (33.0–56.0) 43.0 (32.0–55.0)
 By group (years)    
  ≤ 19 12 (2.4%) 1 (0.6%) 13 (2.0%)
  20–39 204 (41.3%) 64 (38.3%) 268 (40.5%)
  40–59 207 (41.9%) 71 (42.5%) 278 (42.1%)
  60–79 69 (14.0%) 29 (17.4%) 98 (14.8%)
  ≥ 80 2 (0.4%) 2 (1.2%) 4 (0.6%)
 Not reported 0 1 1
Previous TB treatment n = 478 n = 165 n = 643
 Yes 394 (82.4%) 138 (83.6%) 532 (82.7%)
 No 84 (17.6%) 27 (16.4%) 111 (17.3%)
 Not reported 16 3 19
Financially supported through social health insurance n = 311 n = 147 n = 458
 Yes 224 (72.0%) 109 (74.1%) 333 (72.7%)
 No 87 (28.0%) 38 (25.9%) 125 (27.3%)
 Not reported 183 21 204
HIV status n = 453 n = 74 n = 527
 Positive 32 (7.1%) 5 (6.8%) 37 (7.0%)
 Negative 421 (92.9%) 69 (93.2%) 490 (93.0%)
 Not reported 41 94 135
Other comorbidities n = 312 n = 146 n = 458
 Diabetes 44 (14.1%) 8 (5.5%) 52 (11.4%)
 Heart disease 12 (3.8%) 6 (4.1%) 18 (3.9%)
 Liver disease 13 (4.2%) 7 (4.8%) 20 (4.4%)
 Kidney disease 2 (0.6%) 0 (0%) 2 (0.4%)
 Malnutrition 7 (2.2%) 7 (4.8%) 14 (3.1%)
 Psychiatric disorder 13 (4.2%) 0 (0%) 13 (2.8%)
 Respiratory disordera 32 (10.3%) 22 (15.1%) 54 (11.8%)
 Substance abuse 8 (2.6%) 10 (6.8%) 18 (3.9%)
 Otherb 10 (3.2%) 3 (2.1%) 13 (2.8%)
 Not reported 182 22 204
Infection site n = 481 n = 164 n = 645
 Pulmonary 458 (95.2%) 164 (100.0%) 622 (96.4%)
 Extra-pulmonary 12 (2.5%) 0 (0%) 12 (1.9%)
 Both 11 (2.3%) 0 (0%) 11 (1.7%)
 Not reported 13 4 17
Initial sputum smear grade n = 474 n = 146 n = 620
 Negative 162 (34.2%) 66 (45.2%) 228 (36.8%)
 Scanty 8 (1.7%) 6 (4.1%) 14 (2.3%)
 1 +  185 (39.0%) 23 (15.8%) 208 (33.5%)
 2 +  54 (11.4%) 26 (17.8%) 80 (12.9%)
 3 +  65 (13.7%) 25 (17.1%) 90 (14.5%)
 Not reported 20 22 42
Antibiotic resistance at enrolment n = 309 n = 132 n = 441
 RR-/MDR-TB only 257 (83.2%) 131 (98.5%) 388 (88.0%)
 Pre-XDR-TB 35 (11.3%) 1 (1.5%) 36 (8.2%)
 XDR-TB 17 (5.5%) 0 (0%) 17 (3.8%)
 Not reported 185 36 221
  1. Bolded numbers indicate the number of individuals for whom data were available (percentages exclude those for whom data were not reported)
  2. aRespiratory disorder refers to either: atelectasis, bronchiectasis, bronchitis, bronchopneumonia, chronic pulmonary disease, lung tumor, pneumonia, pneumothorax, or respiratory failure
  3. bOther comorbidity refers to either: adrenal failure, anemia, esophageal cancer, gout, pleural effusion, or seizure